KIR2DL1 and glioblastoma: In the present study, we aimed to analyze the frequency, phenotype, and function of KIR2DL-1,-2/3 expressing NK-cells in glioblastoma patients and to evaluate whether targeting of KIR2DL-1,-2/3 augments the cytolytic activity of tumor-derived NK-cells.